REQUEST A DEMO
Total
USD $0.00
Search more companies

Erzsebet Kiralyne - Atak-Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: ERZSEBET KIRALYNE - ATAK-PHARMA Gyogyszertar Bt. Profile Updated: September 04, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Erzsebet Kiralyne - Atak-Pharma Bt. is based in Hungary. The head office is in Kiskunhalas. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on November 22, 1995. It currently has a total number of 7 (2023) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 7.89% in 2022. Its’ total assets recorded a growth of 3.49%. Erzsebet Kiralyne - Atak-Pharma Bt.’s net profit margin decreased by 0.91% in 2022.

Headquarters
Kun ter 1. fszt. 1.
Kiskunhalas; Bacs-Kiskun; Postal Code: 6400

Contact Details: Purchase the Erzsebet Kiralyne - Atak-Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Erzsebet Kiralyne - Atak-Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Erzsebet Kiralyne - Atak-Pharma Bt. report to view the information.
Registered Capital:
Purchase the Erzsebet Kiralyne - Atak-Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Erzsebet Kiralyne - Atak-Pharma Bt. report to view the information.
Incorporation Date:
November 22, 1995
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Erzsebet Kiralyne - Atak-Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.89%
Total operating revenue
8.05%
Operating profit (EBIT)
-32.45%
EBITDA
-31.92%
Net Profit (Loss) for the Period
-35.11%
Total assets
3.49%
Total equity
1.99%
Operating Profit Margin (ROS)
-0.93%
Net Profit Margin
-0.91%
Return on Equity (ROE)
-4.56%
Quick Ratio
0.02%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?